Mobile Electronic Patient-Reported Outcomes and Interactive Support During Breast and Prostate Cancer Treatment: Health Economic Evaluation From Two Randomized Controlled Trials
JMIR Cancer · 2025
DOI: 10.2196/53539 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift JMIR Cancer, 2025. Verfasst von Marie-Therése Crafoord und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nursing, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Patient Reported Outcome Measures, Prostatic Neoplasms, Breast Neoplasms, Mobile Applications. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Digital interventions for supportive care during cancer treatment incorporating electronic patient-reported outcomes (ePROs) can enhance early detection of symptoms and facilitate timely symptom management. However, economic evaluations are needed.
Objective
This study aims to conduct a cost-utility analysis of an app for ePRO and interactive support from the perspective of the payer (Region Stockholm Health Care Organization) and to explore its impact on patient health care utilization and costs.
Methods
Two open-label randomized controlled trials (RCTs) were conducted, including patients undergoing neoadjuvant chemotherapy for breast cancer (B-RCT; N=149) and radiotherapy for prostate cancer (P-RCT; N=150), recruited from oncology clinics at 2 university hospitals in Stockholm, Sweden. EORTC QLQ-C30 scores were mapped to EQ-5D-3L to calculate quality-adjusted life years (QALYs). Intervention and implementation costs and health care costs, obtained from an administrative database, were used to calculate incremental cost-effectiveness ratios (ICERs) in 3 ways: including all health care costs (ICERa), excluding nonacute health care costs (ICERb), and excluding health care costs altogether (ICERc). Nonparametric bootstrapping was used to explore ICER uncertainty. Health care costs were analyzed by classifying them as disease-related or acute.
Results
In both RCT intervention groups, fewer QALYs were lost compared with the control group (P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Nursing, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
- Faculty of Health Science, Kristianstad University, Kristianstad, Sweden.
- Function Area Social Work in Health Care, Karolinska University Hospital, Stockholm, Sweden.
- Academic Primary Care Centre, Region Stockholm, Stockholm, Sweden.
ORCID-Profile: Marie-Therése Crafoord, Joakim Ekstrand, Kay Sundberg, Marie I Nilsson, Maria Fjell, Ann Langius-Eklöf
Zitieren
APA
Crafoord, M. T., Ekstrand, J., Sundberg, K., Nilsson, M. I., Fjell, M., & Langius-Eklöf, A. (2025). Mobile Electronic Patient-Reported Outcomes and Interactive Support During Breast and Prostate Cancer Treatment: Health Economic Evaluation From Two Randomized Controlled Trials. JMIR Cancer. https://doi.org/10.2196/53539
Vancouver
Crafoord MT, Ekstrand J, Sundberg K, Nilsson MI, Fjell M, Langius-Eklöf A. Mobile Electronic Patient-Reported Outcomes and Interactive Support During Breast and Prostate Cancer Treatment: Health Economic Evaluation From Two Randomized Controlled Trials. JMIR Cancer. 2025. doi:10.2196/53539
BibTeX
@article{Crafoord2025,
author = {Crafoord, Marie-Therése and Ekstrand, Joakim and Sundberg, Kay and Nilsson, Marie I and Fjell, Maria and Langius-Eklöf, Ann},
title = {Mobile Electronic Patient-Reported Outcomes and Interactive Support During Breast and Prostate Cancer Treatment: Health Economic Evaluation From Two Randomized Controlled Trials},
journal = {JMIR Cancer},
year = {2025},
doi = {10.2196/53539}
}
EUVIMED